Myeloma
Study results from University of Minnesota, Medical Department update understanding of myeloma
Published in Surgery Litigation and Law Weekly, February 26th, 2010
"Local recurrence with subsequent osteolysis is a problem after intralesional curettage of giant cell tumor of bone, myeloma, and metastatic carcinoma. The bisphosphonate zoledronic acid (zoledronate) has been shown to reduce osteoclast activity, and its local administration is a potentially attractive therapy, especially for the osteoclast-rich giant cell tumor," scientists writing in the Journal of Bone and Joint Surgery - American Volume report.
"The aim of this study was to analyze the elution dynamics of zoledronic acid release from acrylic bone cement and its in vitro antitumor efficacy. Various concentrations of zoledronic acid were mixed with bone cement...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Chemotherapy
Study results from Tufts Medical Center broaden understanding of chemotherapy - Life Sciences
New life sciences in children study findings have been reported by researchers at Taipei Medical University, Department of Emergency Medicine - Medtronic, Inc.
German Appeals Court Says CoreValve Devices From Medtronic Do Not Infringe Edwards Lifesciences' Andersen Patent - NMT Medical, Inc.
NMT Medical Reports Preliminary Full Year 2009 Revenues of Approximately $13.2 Million - People for the Ethical Treatment of Animals PETA
PETA Says Annual Intake Numbers Released Today Show Need for Mandatory State Spay-and-Neuter Laws - Abscess Therapy
Researchers from Tri-Service General Hospital, Department of Internal Medicine discuss findings in abscess therapy - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
